Updates are available Correction dated 2023-07-26
Click to view Correction: https://doi.org/10.1186/s12879-023-08450-2
-
Authors
Ramillon, Julien
de Lamballerie, Xavier
Robineau, Olivier
Blanché, Hélène
Severi, Gianluca
Touvier, Mathilde
Zins, Marie
Carrat, Fabrice
,
Ancel, Pierre-Yves
Charles, Marie-Aline
Kab, Sofiane
Renuy, Adeline
Le-Got, Stéphane
Ribet, Céline
Wiernik, Emmanuel
Goldberg, Marcel
Artaud, Fanny
Gerbouin-Rérolle, Pascale
Enguix, Melody
Laplanche, Camille
Gomes-Rima, Roselyn
Hoang, Lyan
Correia, Emmanuelle
Barry, Alpha Amadou
Senina, Nadège
Szabo de Edelenyi, Fabien
Druesne-Pecollo, Nathalie
Esseddik, Younes
Hercberg, Serge
Benhammou, Valérie
Ritmi, Anass
Marchand, Laetitia
Zaros, Cécile
Lordmi, Elodie
Candea, Adriana
de Visme, Sophie
Simeon, Thierry
Thierry, Xavier
Geay, Bertrand
Dufourg, Marie-Noëlle
Milcent, Karen
Lusivika-Nzinga, Clovis
Pannetier, Gregory
Lapidus, Nathanael
Goderel, Isabelle
Dorival, Céline
Nicol, Jérôme
Lai, Cindy
Esperou, Hélène
Couffin-Cadiergues, Sandrine
Gagliolo, Jean-Marie
Sebaoun, Jean-Marc
Beaudoin, Jean-Christophe
Gressin, Laetitia
Morel, Valérie
Ouili, Ouissam
Deleuze, Jean-Francois
Priet, Stephane
Saba Villarroel, Paola Mariela
Fourié, Toscane
Mohamed Ali, Souand
Amroun, Abdenour
Seston, Morgan
Ayhan, Nazli
Pastorino, Boris
Pellicer, Mireille
Allegre, Julien
Deschasaux, Mélanie
Rahib, Delphine
Lydie, Nathalie
Robineau, Olivier
Belhadji, Liza
Ninove, Laetitia
,
Bajos, Nathalie
Ancel, Pierre-Yves
Charles, Marie-Aline
Jusot, Florence
Martin, Claude
Meyer, Laurence
Pailhe, Ariane
Spire, Alexis
Rouquette, Alexandra
Lapidus, Nathanaël
- License Information
-
More Information
Article History
Received: 30 June 2022
Accepted: 14 March 2023
First Online: 14 April 2023
Change Date: 26 July 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12879-023-08450-2
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments. The SAPRIS survey was approved by the Inserm ethics committee (approval #20–672 dated March 30, 2020). The SAPRIS-SERO study was approved by the Sud-Mediterranee III ethics committee (approval #20.04.22.74247).Ethical approval and written or electronic informed consent were obtained from each participant before enrolment in the original cohort. Electronic informed consent was obtained from all participants for DBS testing.
: Not applicable.
: Prof Fabrice Carrat reports personal fees from Sanofi, unrelated to the submitted work. Dr Olivier Robineau reports personal fees from MSD, Gilead, ViiV, unrelated to the submitted work.All other authors declare no competing interest.
